AI search tool helps physicians to find the perfect clinical trials for their patients
A newly developed search tool uses AI to understand patient needs and reccomend the best clinical trials for their treatment, whilst keeping physicians centered in the process to ensure the best care.
myTomorrows, a company with a missions to connect patients, physicians and biopharma companies to reach solutions that benefit everyone, have launched a clinical trial database search tool to help patients.
The tool, TrialSearch AI, is a physician-focused, pre-screening clinical trial search tool that uses AI technology to assist physicians in identifying clinical trials or expanded access programmes that could be beneficial for their patients.
In normal practice, a physician will go through a patients entire medical background, and compare this to a myriad of specific clinical trial criteria – a time consuming activity. TrialSearch AI provides a much faster, more efficient way of doing this by running a side by side comparison of patient medical history and publicly available clinical trial eligibility criteria or expanded access programme criteria from programmes around the world. Once the tool has run the search, it requests that the physician complete some further manual checks, and whether a pre-approval option is applicable for particular patients.
The tool can reduce the time physicians spend manually searching for trials by up to 90%, whilst still maintaining the layer of human decision making to give patients the best opportunity for personalised care.
The tools should be able to help patients with unmet needs and be especially useful for those with rare diseases.
“Our team of researchers and developers designed TrialSearch AI to bring greater speed, transparency, and accuracy to the complex, time-consuming task of manually searching for clinical trials. As a physician who cared for patients diagnosed with cancer, I know first-hand the importance of providing actionable information that can help physicians, patients, and caregivers discover and access potentially life-saving treatments,” commented Michel van Harten, CEO of myTomorrows.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Pharmapack 2024 - From the Floor
Paris once again welcomes Europe’s leading trade show in pharmaceutical packaging and drug delivery innovation. Join our content team as Pharmapack 2024 opens its doors to leading experts and innovators in pharmaceutical packaging and drug delive... -
News On Track at Pharmapack 2024 - The Track Sponsor interview: BD Pharmaceuticals
January 2024 brings both a new year and Europe’s leading packaging and drug delivery event. Bringing the world’s experts in pharmaceutical packaging together in Paris, France, Pharmapack 2024 brings exciting opportunities to learn and colla... -
News CPHI Pharma Awards 2023 – API Development and Innovation Winners: Snapdragon Chemistry, a Cambrex Company
After another year of impressive nominations for the CPHI Pharma Awards our winners were announced at CPHI Barcelona in October. In this series of interviews, we speak to the teams behind the award-winning projects, concepts, and technologies. -
News PharmaKure gains authorisation for next stage testing on Alzheimer's treatment
Clinical stage pharmaceutical company PharmaKure gains permission from UK authorities to enter into further testing for PK051 for the treatment of patients with mild cognitive impairment associated with Alzheimer's disease. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News Navigating the Future: Challenges and Opportunities in Pharma Innovation and Investment – CPHI Barcelona 2023 Roundtable Report
In this comprehensive downloadable report, hear from a range of experts in finance and investment in the pharma industry on what investment trends will be shaping the future of the industry, in Catalonia, and the wider world. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance